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EchocardiographyAbstract Background: Right ventricular (RV) apical pacing, induces asynchronous ventricular
contraction and impairs cardiac function. Alternative sites of pacing particularly right ventricular
outﬂow tract (RVOT) may have a more favorable hemodynamic proﬁle, physiological left ventric-
ular (LV) activation and normal ventricular contraction pattern. The Aim of the study was to ﬁnd
out the best alternative sites to RV apex for permanent pacemaker (PM) lead ﬁxation in the RVOT,
based on the width of the QRS in the surface ECG.
Patients and methods: The study included 69 patients with pacemaker-dependent complete heart
block; 35with active pacemaker lead ﬁxation in the site which achieved narrowest max. QRS duration
in the RVOT (group 1) and 34 with active pacemaker lead ﬁxation in RV apex (group 2).
Results: High RVOT septum was the site which achieved the narrowest QRS duration on surface
ECG (117.86 ± 8.43 ms) when compared with RV apex (140.29 ± 13.14) (p< 0.001). There was a
marked LV asynchrony after 3 months in group 2; IVMD (51.67 ± 14.06 ms), LVPEP (191.55
± 36.56 ms), RVPEP (142.45 ± 23.11 ms) and SPWMD (125.64 ± 34.15 ms) when compared to
group 1; IVMD (26.93 ± 12.44 ms), LVPEP (107.32 ± 45.28 ms), RVPEP (76.11 ± 27.66 ms) and
SPWMD (78.15 ± 36.45 ms) (p< 0.001). Tissue Doppler Imaging revealed marked difference on
the opposing LV segments mainly between mid-septal and mid-lateral in group 2. The 6 MWT was
much better in group 1 patients (473 ± 240 m) than in group 2 patients (308 ± 221 m) (p< 0.001).
Conclusion: High RVOT septum is the ideal site for PM lead implantation. Compared with RV
apical pacing, it is associated with improvement in functional and hemodynamic parameters over
medium-term follow-up.
 2016 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Right ventricular apical pacing produces abnormal and pro-
longed left ventricular (LV) activation with consequent
mechanical dyssynchrony and dysfunction.1 The previous
238 H.S. Roshdy et al.deleterious effects led to the utilization of new pacing sites
namely, the mid-RV septal and the RV outﬂow tract (RVOT),
which showed better hemodynamic proﬁle due to the pre-
sumed more physiologic activation pattern, in addition to
the more practical approach than the His bundle pacing.2,3
However, due to the multiplicity of possible lead positions
alternative pacing sites have yielded conﬂicting and controver-
sial results.4
Since the septal regions normally depolarize ﬁrst, RV septal
pacing could achieve a more favorable ventricular contraction
pattern. Such strategic sites could be found by endocardial
mapping during pacemaker implantation. Based on this
concept, we investigated the feasibility of RVOT endocardial
mapping to identify optimal anatomical locations for lead
placement.5
The Aim of this work was to ﬁnd out alternative sites to RV
apex for PM lead ﬁxation which minimizes LV dyssynchrony
and subsequent complications, and to prove the clinical beneﬁt
of RVOT pacing in increasing the patients exercise capacity.A 
B 
Figure 1 Fluoroscopic image of the heart in 30 RAO projection
showing a quadripolar deﬂectable catheter just below the pul-
monary valve marking the upper border of the RVOT (line A),
and a bipolar pacing electrode in the RV apex with its highest
point in its shaft marking the TV apex and the lower border of the
RVOT (line B).2. Patients and methods
This prospective case-control study was conducted in Cardiol-
ogy Department, Zagazig University Hospitals. We included
103 patients admitted to the cardiology department between
September 2013 and September 2015 with 3rd degree AV
block. Informed consent was obtained from all patients; the
study was approved by the ethics and medical research com-
mittee in Zagazig University, thirty four patients were
excluded during the study due to pacing percentage less than
90%, and sixty nine patients completed the study.
1. Grouping of patients:
The patients were randomly divided into two groups, and
every other patient was assigned to one of two groups:
group 1 (case group) included 35 patients where PM leads
were inserted into any of the following RV positions (High
RVOT septum, Mid RVOT septum, Low RVOT septum,
High RVOT free wall and Low RVOT free wall) selected
according to which site had the narrowest surface ECG
QRS duration after pacing on these sites by intra-cardiac
catheter and group 2 (control group) included 34 patients
where PM active leads were inserted directly into RV apex.
2. Exclusion criteria:
We excluded patients with atrial ﬁbrillation, ejection frac-
tion less than 50%, ischemic heart disease, rheumatic valvu-
lar heart disease, any myocardial disease, congenital heart
block, patients independent on the pacemaker (less than
90% dependence on the pacemaker as revealed during
pacemaker programming, or the presence of indigenous
rhythm in ECG during evaluation of the patient) and any
patient with a comorbidity that can affect the 6 MWT
result (e.g. musculo-skeletal disease, organ failure, BMI
more than 30 kgm/m2, anemia, negative inotropic medica-
tions and DM).
3. Pacemaker implantation:
3.1. Initial pace mapping: All patients included in
group 1 were submitted to RVOT pacing using
quadripolar deﬂectable catheter with 5–5 mm
electrode spacing inserted through the femoral
vein into the RV, pacing was applied through thedistal two pools with an amplitude of 2 V with
0.4 ms pulse width using EPS320 Cardiac Stimula-
tor (Micropace Inc., CA, USA), and at a rate of
80/min, the simultaneous standard 12 lead
surface ECG generated from the cardiac pacing
was recorded using multichannel recorder
cardiolab EP recording system (GE healthcare,
WI, USA).
3.2. Anatomical sites Identiﬁcation: the pacing was
applied to the RVOT which was identiﬁed as
follows:
3.2.1. The upper border of the RVOT was identi-
ﬁed by passing the quadripolar catheter in
the 30 RAO view to the pulmonary artery
and withdrawing it gradually until a deﬂec-
tion appears between its distal poles
(recorded on the intra-cardiac channel in
the multi-channel recorder), at that point
the RVOT upper border is noted. The lower
border of the RVOT is identiﬁed by pushing
the temporary pacing electrode in the RV
apex until the shaft of the electrode can no
more be advanced due to contact with the
apex of the tricuspid valve, an imaginary line
is passed from the highest point the shaft can
reach to the lateral cardiac border, that line
represents the lower border of the RVOT
Fig. 1.
3.2.2. Identiﬁcation of selective anatomical sites in
the RVOT:
Once the upper and lower boundaries of the
RVOT identiﬁed, the radiologic view was
changed to LAO 30, the medial aspect of
Figure 2 Differ
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named; (the high septal, the mid septal and
the low septal), the lateral border is divided
into two equal parts named; (the high free wall
and low free wall), each anatomical part was
paced by the quadripolar catheter.3.3. Surface QRS measurement: the QRS resulted from
pacing at different sites was recorded simultane-
ously at the speed of 25 mm/sec, ofﬂine measure-
ments were made using the electronic
measurement package available in the multichannel
recorder, the ﬁrst measurement marker was placed
on the pacing spike, and the second pacing marker
was placed at the junction between the baseline and
the latest QRS of the 12 leads (measuring the widest
QRS of the surface ECG).
3.4. Selection of the PM electrode implantation site: the
anatomical site with the shortest widest QRS is
selected for ﬁxation of the pacemaker electrode
(Fig. 2).
3.5. Fixation of the PM electrode: commercially avail-
able active ﬁxation leads with distal protrusible
helix were used, the stylet of the lead was shaped
into two curves, the proximal was wide ‘‘J” shaped
to pass through the TV to the RVOT, and the distal
was small and in a perpendicular plane to the ﬁrst
with the direction suited to the chosen implantation
site, pacing threshold and sensing threshold were
tested after ﬁxation of the leads.ent ﬂuoroscopic pacing catheter positions with the c
ws the catheter position in the RVOT in 30 LAO
rded at speed of 25 mm/s, with measurement marks
sition.3.6. The pulse generators used were the standard
commercially available VVI pulse generators pro-
grammed at a ﬁxed heart rate of 65 b/min, pacing
output of 3.5 V at 0.4 ms bipolar and sensing
threshold of 2.8 mille volts bipolar.
4. Echocardiography:
Echocardiographic recordings were made using an HP
SONOS (USA), GE Vivid E9 (Norway) and Philips Envi-
sor (the Netherlands). Images were obtained using
2.5 MHz transducers.orresp
proje
in pos4.1. Conventional echocardiography
Complete standard echocardiography, including mea-
surements of Left ventricular end systolic dimension
(LVESD), LV end diastolic dimension (LVEDD),
LV ejection fraction (EF) calculated using cardiac
dimensions, LV end systolic volume (LVESV), LV
end diastolic volume (LVEDV), Left atrium dimen-
sion (LA), Right atrium dimension (RA) and RV
dimension,6 Echocardiography was performed 3 days
and was repeated 3 months following pacemaker
implantation.
4.2. Inter-ventricular dyssynchrony
Pulsed-wave Doppler velocity signals were recorded
from the right and LV outﬂow tracts to measure the
inter-ventricular mechanical delay (IVMD) (time from
the beginning of QRS to the start of pulmonary or aortic
ﬂow). The difference between pre-ejection times IVMD
was used as an indicator of synchronicity between right
and LV contraction.7,8onding simultaneous 12 leads recording during pacing. The
ction, and the lower panel shows the paced surface QRS
ition for the ﬁrst group and the corresponding Max. QRS
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Intra-ventricular mechanical delay could be determined
on the basis of the simple M-mode-derived septal to pos-
terior wall motion delay (SPWMD). SPWMD was the
difference between the time from the onset of ECG-
derived Q wave to the initial peak posterior displace-
ment of the septum, and the time from the onset of
QRS to the peak systolic displacement of posterior
wall9,10, the time interval between the onset of ECG-
derived QRS and the myocardial systolic velocity (Sm)
peak (=time to Sm peak) and the time interval between
the onset of QRS and the onset of Sm (=time to Sm
onset), which correspond to left ventricular pre-
ejection period (LVPEP), also RV pre-ejection period
was calculated (RVPEP) in the same way11. Dyssyn-
chrony was also assessed by using the measure of elec-
tromechanical delay (the time between the beginning
of the QRS complex and the peak systolic wave of tissue
Doppler) in the basal and mid regions of different
opposing LV walls.5. Six-minute walk test
The test was used to evaluate the exercise capacity of the
patients, all patients were submitted to the test one month
after PM implantation, and the test was conducted accord-
ing to Enright, 2003.12 To reduce the bias, we used the
following formula: predicted 6 min walk distance in
meters = 218 + (5.14  height in cm  5.32  age in
years)  1.8  weight in kg + (51.31  sex (1 for male
and 0 for female)),13 to correct the results according to
the different physiologic co-variables, and results were
expressed as percentage of archived from expected by the
formula.
6. Statistical analysis:
Statistical analysis was performed using the Statistical
Package for Social Sciences version 16.0 (SPSS fore 1 The demographic data, QRS duration before and after PM
bles Group 1
ber 35
(years)* 65.46 ± 10.61
gender n (%) 27 (77.1%)
duration (ms)
cape rhythm* 138.29 ± 12.00
st-pacemaker* 117.86 ± 8.43
QRS duration change* 14.4 ± 6.44%
paced beats (3 months)* 94.8 ± 3.33%
ean ± SD.
e 2 QRS duration and number of the narrowest QRS duratio
f PM lead ﬁxation in the RVOT Max. QRS duration (ms)
septum 100.69 ± 17.22
septum 109.89 ± 16.68
septum 115.42 ± 15.60
free wall 110.54 ± 17.10
free wall 131.31 ± 13.90
NOVA statistical value.Windows 16.0, Inc., Chicago, IL, USA). Regarding the
main measured parameters, the differences in both groups
(1 and 2) were tested by using independent samples t-test
and homogeneity of variances was analyzed by the Levene’s
test. Results were expressed as Mean ± standard deviation
(SD). Categorical data are presented as absolute numbers
and percentages within brackets. A v2 analysis or Fisher
exact test was used to compare these variables when
expected cell frequency was less than ﬁve. Correlations
between categorical data are done using spearman correla-
tion coefﬁcient. All P values were based on a 2-tailed distri-
bution, and the corresponding P-value: non-signiﬁcant
difference if P> 0.05, signiﬁcant difference if P< 0.05,
and highly signiﬁcant difference if P< 0.001.
3. Results
The demographic data, QRS duration before and after PM
implantation and percentage of difference between pre and
post pacemaker implantation are summarized in Table 1.
There was no statistically signiﬁcant difference between the
two groups regarding age and gender (p> 0.05).
After PM insertion, there was highly statistically signiﬁcant
difference among both groups in QRS duration with statisti-
cally signiﬁcant decrease in QRS duration in group 1 and
statistically signiﬁcant increase in QRS duration in group 2
(14.4 ± 6.44% versus 14.2 ± 11.8%) (P< 0.001).
Percentage of paced beats at 3 month follow-up was above
90% for both groups with no statistically signiﬁcant difference
between them (94.8 ± 3.33% vs. 94.5 ± 2.53% p= 0.36).
The max Surface ECG QRS duration of various positions
after RVOT pace-mapping with intracardiac catheter and the
sites of PM leads ﬁxation in group 1 are listed in Table 2. There
was a highly statistically signiﬁcant difference between theimplantation and percentage of pacing at 3 months follow-up.
Group 2 P-value
34
68.62 ± 8.98 0.19
26 (76.5%) 0.59
123.24 ± 8.06 <0.001
140.29 ± 13.14 <0.001
14.2 ± 11.8% <0.001
94.5 ± 2.53% 0.36
ns according to pacing position in group 1.
Mean ± SD F* p-value NO %
17.015 <0.0001 31 88.6
1 2.9
2 5.6
1 2.9
0 0
Table 3 Echocardiographic variables measured in both groups after 3 days and follow-up after 3 months of PM implantation.
Parameters Echocardiography after 3 days Echocardiography after 3 months
Group 1* Group 2* P-value Group 1* Group 2* P-value
LVESD (mm) 50.23 ± 4.44 51.01 ± 5.23 =0.14 50.23 ± 4.21 50.88 ± 5.45 =0.11
LVEDD (mm) 32.77 ± 4.32 30.66 ± 4.67 =0.09 33.11 ± 5.23 33.46 ± 6.11 =0.13
EF (%) 61.34 ± 3.42 60.53 ± 4.11 =0.06 60.55 ± 5,54 60.44 ± 6.81 =0.23
LA (mm) 34.33 ± 5.01 34.54 ± 5.33 =0.12 34.11 ± 3.91 33.06 ± 5.94 =0.03
RA (mm) 28.74 ± 5.65 29.09 ± 4.65 =0.22 28.67 ± 4.55 33.94 ± 6.54 =0.02
RV (mm) 25.10 ± 5.43 25.88 ± 4.63 =0.11 25.45 ± 4.55 27.56 ± 5.87 =0.04
LVESV (ml) 49.56 ± 8.03 50.86 ± 7.06 =0.07 50.34 ± 8.67 53.10 ± 8.65 =0.02
LVEDV (ml) 127.56 ± 17.11 129.89 ± 19.78 =0.09 127.22 ± 19.90 134.25 ± 19.02 =0.03
IVMD (ms) 27.45 ± 13.55 51.45 ± 15.31 <0.001 26.93 ± 12.44 51.67 ± 14.06 <0.001
LVPEP (ms) 105.39 ± 44.48 189.34 ± 36.14 <0.001 107.32 ± 45.28 191.55 ± 36.56 <0.001
RVPEP (ms) 75.33 ± 23.20 140.15 ± 24.58 <0.001 76.11 ± 27.66 142.45 ± 23.11 <0.001
SPWMD (ms) 76.45 ± 30.03 124.22 ± 34.15 <0.001 78.15 ± 36.45 125.64 ± 34.15 <0.001
SM peak – SM onset (ms) 40.33 ± 13.74 62.55 ± 13.22 <0.001 40.65 ± 16.20 66.69 ± 18.45 <0.001
LVESD: LV end systolic diameter), LVEDD: LV end diastolic diameter, LA: left atrium, RA: right atrium, RV: right ventricle, LVESV: LV end
systolic volume, LVEDV: LV end diastolic volume, IVMD: interventricular mechanical delay, LVPEP: LV pre-ejection period, RVPEP: RV
pre-ejection period, SPWMD: septal to posterior wall motion delay, SM peak – SM onset: time from Sm wave peak minus time to Sm wave
onset.
* Mean ± SD.
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showed that the signiﬁcant statistical difference between the
QRS duration in different pacing sites was due to the shorter
QRS in high septal region compared to the low septal and
low free wall, while the difference between high septal and high
free wall and mid septal positions was not signiﬁcant.
The PM ﬁnal lead ﬁxation site was in the high septum in 31
patients (88.6%), mid septal in one patient (2.9%), low septal
in 2 patients (5.6%), high free wall in one patient (2.9%) and
none in the low free wall site.
Echocardiographic variables measured in both groups after
3 days and the follow-up after 3 months are listed in Table 3.
In echocardiography done after 3 days, there was no statisti-
cally signiﬁcant difference between the two groups in LVESD,
LVEDD, EF, LA, RA, RV, LVESV and LVEDV (P> 0.05)
while there was highly signiﬁcant increase in IVMD (27.45
± 13.55 ms versus 51.45 ± 15.31 ms), LVPEP (105.39
± 44.48 ms versus 189.34 ± 36.14 ms), RVPEP (75.33
± 23.20 ms versus 140.15 ± 24.58 ms), SPWMD (76.45
± 30.03 versus 124.22 ± 34.15 ms) and Time to SM peak-
time to SM onset (40.33 ± 13.74 ms versus 62.55
± 13.22 ms) (P< 0.001) in group 2 in comparison with group
1. After 3 months still no statistically signiﬁcant difference
between two groups in LVESD, LVEDD and EF but there
was statistically signiﬁcant increase in LA (34.11 ± 3.91 mm
versus 33.06 ± 5.94 mm), RA (28.67 ± 4.55 mm versus
33.94 ± 6.54 mm), RV (25.45 ± 4.55 mm versus 27.56
± 5.87 mm), LVESV (50.34 ± 8.67 ml versus 53.10
± 8.65 ml) and LVEDV (127.22 ± 19.90 ml versus 134.25
± 19.02 ml) (P< 0.05). Also there was a highly signiﬁcant
increase in IVMD (26.93 ± 12.44 ms versus 51.67
± 14.06 ms), LVPEP (107.32 ± 45.28 ms versus 191.55
± 36.56 ms), RVPEP (.76.11 ± 27.66 ms versus 142.45
± 23.11 ms), SPWMD (78.15 ± 36.45 versus 125.64
± 34.15) and Time to SM peak-time to SM onset (40.65
± 16.20 ms versus 66.69 ± 18.45 ms) (P< 0.001).Tissue Doppler imaging revealed no statistically signiﬁcant
difference between the two groups regarding synchronization
between most pairs of the opposing LV segments including
basal septal and basal lateral, basal anterior and basal inferior
and mid anterior and mid inferior but there was statistically
signiﬁcant difference between the two groups in tissue Doppler
imaging of mid-septal and mid-lateral segments (P= 0.03) in
echocardiography done after 3 days of PM insertion. Follow-
up measurements taken After 3 months, were still showing
no statistically signiﬁcant difference between the two groups
in the mid anterior and mid inferior segments only
(P> 0.05) but there was highly statistically signiﬁcant differ-
ence between the two groups in tissue doppler imaging of other
segments including basal septal and basal lateral, basal ante-
rior and basal inferior and mid-septal and mid-lateral
(P< 0.001) Table 4.
6 MWT was performed by all patients and there was highly
statistically increase in the distance (473 ± 240 m versus 308
± 221 m) and percentage of walked distance in relation to
expected for each patient (72 ± 33% versus 48 ± 30%,
p< 0. 005) in group 1 in comparison with group 2 Table 5.
4. Discussion
Prolonged RV apical pacing has been shown to be associated
with progressive left ventricular dysfunction manifested as
heart failure, atrial ﬁbrillation and an increased both morbid-
ity and mortality.14–18 All the previous data directed the atten-
tion toward ﬁnding alternative sites for cardiac pacing that –at
the same time-easy and safe to initiate. In our study the Aim
was to get the best results, as well as to avoid the complications
associated with RV apical pacing when using VVI pacemakers.
The majority of our patients are only eligible to implant VVI
pacemakers due to limited ﬁnancial plans. We tried previously
direct His bundle pacing,3 but the procedure was long, compli-
cated and needed a long time to acquire the experience, yet it
Table 4 Tissue Doppler imaging of opposing LV segments after 3 days and follow-up after 3 months of PPM insertion.
Opposing walls Diﬀerences After 3 days P value After 3 months P value
Group 1 Group 2 Group 1 Group 2
NO % NO % NO % NO %
Basal septal – basal lateral (ms) <60 ms 27 77.1 21 61.8 0.17 23 65.7 7 20.6 <0.001
P60 ms 8 22.9 13 38.2 12 34.3 27 79.4
Mid-septal – Mid-lateral (ms) <60 ms 24 68.6 16 47.1 0.03 23 65.7 9 26.5 <0.001
P60 ms 11 31.4 18 52.9 12 34.3 25 73.5
Basal anterior Basal inferior (ms) <60 ms 28 80.0 25 73.5 0.09 28 80.0 11 32.4 <0.001
P60 ms 7 20.0 9 26.5 7 20.0 23 67.6
Mid anterior – Mid inferior (ms) <60 ms 28 80.0 24 70.6 0.24 28 80.0 19 55.9 0.08
P60 ms 7 20.0 10 29.4 7 20.0 15 44.1
Table 5 6 MWT in both groups.
Group 1 Group 2 P value
Achieved distance (m) 473 ± 240 308 ± 221 0.004
Achieved percentage (%) 72 ± 33 48 ± 30 0.002
242 H.S. Roshdy et al.gave very good results regarding QRS width and improving
exercise capacity.
There is a direct relation between pre- and post-pacing QRS
durations.19 When pre-pacing escape QRS duration was com-
pared between groups 1 and 2, Group 2 showed shorter QRS
duration 123.24 ± 8.06 versus 138.29 ± 12 ms P< 0.001 in
group 1, which reﬂects more His-Purkinje system dysfunction
in group 1. The post pacing QRS duration – as expected-
increased in group 2 by 14.2 ± 11.8%. That was not the case
in group 1, although patients in group 1 initially had longer
escape QRS, the post-pacing QRS reduced by 14.4 ± 6.44%,
and the net QRS duration was signiﬁcantly shorter than
patients in group 2. It seems that our current approach did
not only improve ventricular synchronization, expressed as
QRS width, but it also did so irrespective to the condition of
the His-Purkinje system.
In the early attempts to initiate RVOT and septal pacing
QRS width in surface ECG was the ﬁrst to be observed as
an indicator of optimum pacing site.20 In our study, the major-
ity of patients (88.6%) in group 1 had narrowest QRS duration
in the high RVOT septum, which also showed the shortest
mean QRS duration among the other pacing sites in the
RVOT. These results were consistent with Pastore et al.,
2012, who explained that the high septal region of the LV
normally depolarizes ﬁrst and high RV septal pacing close to
the sites of early activation could achieve the narrowest surface
ECG QRS duration.21 Although they did not made the same
anatomical classiﬁcation of the outﬂow tract, the septal region
of the outﬂow tract was the site which achieved the narrowest
QRS and the best ventricular synchronization, when they
adopted electro-ﬂuoroscopic approach similar to the approach
we used. Likewise, Nakamura et al., 2011 found that the septal
RV regions showed the shortest QRS duration when compared
to RV apex and other regions in the RVOT including the free
wall.22 In the same way Coppola et al., 2015 observed that the
QRS duration was shorter in the high outﬂow tract, either
septal or free wall.23 That support our results that showed that
the main statistical difference between the RVOT pacing sites
was due to the difference between the upper and lower pacingsites and the difference between the upper free wall and septal
regions was not signiﬁcant, likewise for the lower RVOT
regions. In conclusion most of the recent studies support the
idea that RVOT pacing is better than RV apical pacing and
that higher RVOT is better than lower RVOT, and septal
regions in general are better than free wall in terms of QRS
duration.
The LV volumes did not show any difference between the
two groups measured 3 days after PM implantation. But even
being as early as 3 months all the LV volumes started to
increase in group 2 in comparison with group 1 indicating that
the delirious effects of RV apical pacing started to take place.
But on the other hand the LVESD, LVEDD and EF did not
show any difference between the two groups even when mea-
sured after 3 months, which gives an indicator on the limited
value of these measurements in evaluating LV changes in such
early time; the value of EF could have been enhanced if the
Simpson’s technique was employed in its calculation; and
IVMD, LVPEP and RVPEP were able to detect the difference
between the two groups as early as 3 days after PM implanta-
tion and continued to detect that difference thereafter. Many
studies agreed with these results24–26 and revealed that patients
with LV dyssynchrony after long-term RV pacing showed a
decrease in LV ejection fraction, with an increase in LV
volumes, and also, revealed an increase in IVMD, LVPEP,
RVPEP and SPWMD, after long-term RV pacing. In short
once the apical RV pacing is initiated and depending on the
degree of patient dependence on the pacemaker, morphologi-
cal and functional changes start to occur, and even a short
period of RVOT pacing could stop or delay these changes.
When pairs of opposing LV walls were analyzed, only the
mid-septal and mid-lateral pair showed early and late asyn-
chrony in group 2 relative to group 1, while basal septal and
basal lateral and basal anterior and basal inferior pairs showed
only late asynchrony in group 2, and on the other hand mid-
anterior and mid posterior pair, showed no asynchrony when
examined early and late. This observation points to that the
mid lateral region is the region which is most affected by LV
asynchronization produced by RV apical pacing. This was
proved by many studies27–29 which showed that TDI was
signiﬁcantly larger in patients with permanent pacing as com-
pared with control patients and was signiﬁcantly larger in
patients with apical pacing as compared to septal pacing par-
ticularly the septal-to-lateral delay.
All the previous echocardiographic evidence of LV asyn-
chronized contraction, is an evidence of reduced mechanical
Left ventricular dyssynchrony in apical vs. outﬂow tract right ventricular pacing 243efﬁciency of the LV, which is translated into reduction of
patient’s exercise capacity; in this study, evaluation of the exer-
cise capacity was performed using the 6 MWT one month
following the PM implantation; patients in group 1 walked
for longer distances compared to group 2, furthermore, calcu-
lation of the percentage of the achieved from the expected
(calculated) 6 MWT, to correct for different variables that
affect the test other than RV pacing site. These results were
concordant with Occhetta et al., 201525 who revealed that
Exercise tolerance, expressed in meters walked in 6 min, was
more in patients with high RV septal pacing than in RV apical
pacing patients. What is more Tse et al., 200930 found that the
improvement in 6 MWT occurred in the same patient after
upgrading from RV apical pacing to septal pacing and that
improvement continued 18 months after the upgrade. Similarly
Chen et al., 201431 get the same long term improvement in
exercise capacity after 18 months of mid-septal RV pacing.
On the contrary Kypta et al., 200832 revealed that, after anal-
ysis of 98 pacing dependent patients regarding exercise capac-
ity at 3 days, 3 months, and 18 months after the PM
implantation. All changes from baseline to 18 months were
not signiﬁcant between septal and apical pacing sites, they mea-
sured BNP levels and follow-up echocardiography was limited
to LV EF, although they did not support these results with
imaging evidence of asynchronization in these study groups.
5. Conclusion
The present study shows that the high RVOT septum was the
ideal site for PM implantation especially when guided ﬂuoro-
scopically and electrically by an intra-cardiac catheter. High
RVOT septum achieved the narrowest intra-cardiac QRS
duration and also the narrowest surface ECG which is associ-
ated with better echocardiographic and clinical outcomes.
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